Melasma involves ongoing melanin overproduction driven by melanocyte hyperactivity—and unlike post-inflammatory hyperpigmentation, it does not simply fade as skin renews. The condition produces brown or greyish patches most commonly on the cheeks, forehead, upper lip, and chin, triggered by UV exposure, hormonal fluctuations, and genetic predisposition. It affects the epidermis, dermis, or both layers simultaneously—a distinction that determines which treatments will penetrate effectively. Singapore’s year-round high UV index creates persistent triggers, making treatment selection and sun protection equally important for managing this chronic pigmentary disorder.
Melasma Treatment success depends on accurate depth assessment through Wood’s lamp examination, realistic expectations about maintenance requirements, and understanding why certain approaches worsen the condition. Managing melasma in Singapore often combines multiple modalities tailored to individual pigment depth and skin sensitivity.
Understanding Melasma Depth and Type
Wood’s lamp examination reveals whether pigment sits in the epidermis, dermis, or both layers. Epidermal melasma appears more distinct under UV light, responds faster to topical treatments, and shows greater improvement with superficial procedures. Dermal melasma appears less defined, indicates deeper pigment deposition, and requires treatments capable of reaching the mid-dermis without triggering inflammation.
Mixed melasma—the most common presentation—combines both patterns and demands layered treatment approaches. Hormonal melasma linked to pregnancy or oral contraceptives may partially resolve when triggers are removed, while idiopathic cases require ongoing management. Fitzpatrick skin types IV-VI carry higher post-inflammatory hyperpigmentation risk from aggressive treatments.
Topical Treatments: The Foundation
Hydroquinone
Hydroquinone inhibits tyrosinase, the enzyme driving melanin synthesis. Concentrations of 2% are available over-the-counter, while 4% formulations require prescription. Application occurs once or twice daily to affected areas only, with visible lightening typically appearing after 8-12 weeks of consistent use.
Continuous use beyond 4-6 months risks ochronosis—a paradoxical darkening—particularly in darker skin types. Cycling protocols alternate hydroquinone with non-hydroquinone agents to maintain results whilst minimising side effects. Irritation, dryness, and sun sensitivity occur commonly during initial weeks.
Tretinoin and Retinoids
Tretinoin accelerates epidermal turnover, dispersing melanin granules and enhancing penetration of other actives. Concentrations range from 0.025% to 0.1%, with lower strengths reducing irritation risk in sensitive skin. Initial purging and peeling subside after 4-6 weeks of acclimatisation.
Adapalene and retinol offer gentler alternatives with similar mechanisms. Combined with hydroquinone and a mild corticosteroid (triple combination therapy), tretinoin may produce improvement compared to single-agent approaches. Nightly application with gradual frequency increases optimises tolerance.
Azelaic Acid
Azelaic acid at 15-20% concentrations inhibits tyrosinase whilst providing anti-inflammatory benefits. Pregnancy-safe status makes it suitable when hydroquinone is contraindicated. Twice-daily application produces gradual improvement over several months.
Mild stinging on initial application typically resolves within minutes. The compound also addresses any concurrent acne, making it useful for patients managing multiple concerns.
Vitamin C and Other Antioxidants
L-ascorbic acid at 10-20% concentrations provides tyrosinase inhibition alongside antioxidant protection against UV-induced melanogenesis. Morning application under sunscreen enhances photoprotection. Formulation stability matters—vitamin C degrades with light and air exposure.
Niacinamide at 4-5% reduces melanosome transfer to keratinocytes without irritation. Tranexamic acid applied topically or taken orally inhibits plasminogen activation in the melanin pathway. These agents may work alongside melasma prescription treatments.
Chemical Peels: Controlled Exfoliation
Superficial Peels
Glycolic acid peels at 30-50% concentrations remove superficial pigment through controlled epidermal exfoliation. Treatment sessions occur every 2-4 weeks, with a series of 4-6 peels typically needed. Downtime involves mild flaking for 2-3 days.
Mandelic acid provides gentler exfoliation suitable for sensitive or darker skin types with lower post-inflammatory hyperpigmentation risk. Lactic acid offers hydrating properties alongside pigment reduction.
Medium-Depth Peels
Trichloroacetic acid (TCA) at 15-35% penetrates to the papillary dermis, addressing mixed melasma more effectively than superficial options. Frosting during application indicates depth achieved. Recovery requires 7-10 days of visible peeling and redness.
Jessner’s solution combined with TCA enhances penetration whilst allowing lower TCA concentrations. These peels carry higher complication rates in darker skin and require careful administration with proper pre-treatment preparation using topicals.
💡 Did You Know?
Melasma-prone skin contains melanocytes that respond more aggressively to any inflammation or injury. This explains why overly aggressive melasma treatments often worsen the condition—the skin interprets the treatment as damage and produces more pigment as a protective response.
Laser and Light Therapies
Low-Fluence Q-Switched Nd:YAG
Low-fluence settings (1.6-2.5 J/cm²) target melanin without generating the heat that triggers rebound hyperpigmentation. Multiple passes across affected areas during each session gradually fragment pigment. Treatment protocols involve weekly or biweekly sessions, often 8-10 initially.
This approach suits darker skin types better than traditional high-energy lasers. However, hypopigmentation risk exists with excessive treatment—mottled lightening that may be permanent. Practitioners should recognise when to pause treatment cycles.
Picosecond Lasers
Picosecond pulse durations shatter pigment with less thermal damage than nanosecond alternatives. The reduced heat generation may lower rebound risk, though melasma’s unpredictability means no laser approach is risk-free.
Treatment intervals of 4-6 weeks allow skin recovery and pigment clearance assessment. Combining picosecond treatment with topical maintenance may help extend results.
Intense Pulsed Light (IPL)
IPL targets superficial pigment through broad-spectrum light absorption. Better results tend to occur in lighter skin types with epidermal-predominant melasma. Darker skin carries significant burn and hyperpigmentation risk with IPL.
Treatment typically requires 3-5 sessions at monthly intervals. IPL may address concurrent concerns like facial redness or sun damage but is not commonly used as a primary melasma treatment in Singapore.
Fractional Lasers
Non-ablative fractional lasers create microscopic treatment zones, stimulating collagen whilst dispersing pigment. The fractional approach limits total skin injury, reducing downtime and complication rates.
Ablative fractional options (CO2, erbium) remove tissue more aggressively with potentially greater efficacy but also greater risk. These may suit refractory cases when conservative approaches have not produced adequate results, with careful patient selection and pre-treatment optimisation.
⚠️ Important Note
Laser treatment for melasma carries rebound hyperpigmentation risk regardless of device type. The condition’s chronic nature means “clearing” melasma differs from removing a tattoo—melanocytes remain reactive, and triggers persist. Post-laser topical maintenance is an important part of ongoing management, not optional.
Oral Medications
Tranexamic Acid
Oral tranexamic acid at 250mg twice daily may reduce melanogenesis through plasminogen pathway inhibition. A healthcare professional should determine the appropriate dosage and frequency. Clinical improvement may appear after 8-12 weeks of consistent use. The medication may suit patients with melasma that has not responded adequately to topical approaches alone.
Contraindications include history of blood clots, cardiovascular disease, and concurrent use of combined oral contraceptives. Baseline coagulation assessment ensures safety. Most patients tolerate treatment with gastrointestinal upset being the most commonly reported complaint.
Glutathione
Oral or intravenous glutathione is marketed for skin lightening, though evidence supporting melasma-specific efficacy remains limited. The antioxidant may provide modest benefit as an adjunct to established treatments rather than standalone therapy.
Combination Protocols
Melasma treatment in Singapore often layers multiple approaches:
- Phase 1 (Months 1-3): Triple combination topical therapy (hydroquinone, tretinoin, corticosteroid) establishes baseline improvement whilst preparing skin for procedures. Strict sun protection with SPF 50+ broad-spectrum sunscreen, reapplied every 2 hours during outdoor exposure.
- Phase 2 (Months 3-6): Introduction of superficial peels or low-fluence laser based on initial response. Topical maintenance continues, potentially cycling off hydroquinone to non-hydroquinone alternatives.
- Phase 3 (Ongoing): Maintenance protocols help prevent recurrence through continued topical antioxidants, regular sunscreen use, and periodic in-office treatments as needed.
💡 Quick Tip
Apply sunscreen as the final skincare step, using enough product to achieve the labelled SPF—approximately half a teaspoon for face and neck. Physical blockers containing zinc oxide or titanium dioxide may suit melasma-prone skin, as chemical filters may cause irritation in some individuals.
What Our Dermatologist Says
Treatment selection depends on melasma type, skin sensitivity, downtime tolerance, and maintenance commitment. Patients who understand melasma as a chronic condition requiring ongoing management tend to achieve better long-term outcomes than those seeking one-time fixes. Laser treatment means little without daily sunscreen compliance and topical maintenance between sessions.
Building Your Treatment Plan
- Assess your triggers: Identify hormonal factors, sun exposure patterns, and skincare products potentially worsening pigmentation.
- Start conservative: Begin with topical therapy and sun protection before considering procedures. This establishes whether your melasma responds to basic intervention.
- Commit to sunscreen: Treatment is unlikely to succeed without rigorous photoprotection. Visible light also triggers melasma, making tinted sunscreens with iron oxide useful additions.
- Plan for maintenance: Budget time and resources for ongoing management rather than expecting permanent resolution.
- Document progress: Photograph your skin in consistent lighting monthly to track changes that gradual daily viewing misses.
When to Seek Professional Help
- Pigmentation worsening despite over-the-counter treatments
- Uncertainty about whether patches represent melasma or another condition
- Melasma covering large facial areas affecting quality of life
- Previous treatments causing adverse reactions or worsening
- Pregnancy or breastfeeding with melasma concerns
- Desire to explore prescription or procedural options
Commonly Asked Questions
How long before I see results from melasma treatment?
Topical treatments typically show initial improvement after 8-12 weeks of consistent use. Procedural treatments may produce faster visible changes but require the same timeframe for stabilisation. Complete clearance is uncommon—most patients achieve significant fading rather than elimination.
Will my melasma come back after treatment?
Melasma recurrence is common because the underlying melanocyte hyperreactivity persists. Sun exposure, hormonal changes, or discontinuing maintenance therapy frequently triggers return. Ongoing topical treatment and sun protection may minimise recurrence likelihood.
Can I treat melasma during pregnancy?
Azelaic acid, vitamin C, and niacinamide are considered pregnancy-safe options. Hydroquinone, retinoids, and oral tranexamic acid should be avoided. Some pregnancy-related melasma improves postpartum, so conservative management during pregnancy is often appropriate. Please consult a healthcare professional for personalised advice.
Why did my melasma worsen after laser treatment?
Post-inflammatory hyperpigmentation or rebound melasma occurs when treatment triggers the melanocyte hyperactivity it aimed to suppress. This risk increases with aggressive settings, inadequate pre-treatment, or insufficient post-procedure sun protection. Lower-fluence approaches and proper protocols reduce but don’t eliminate this possibility.
Is there a permanent cure for melasma?
Currently, no treatment permanently eliminates melasma. The condition is managed rather than cured. Patients maintaining results long-term combine treatment protocols with lifestyle modifications addressing ongoing triggers.
Next Steps
Melasma requires accurate identification of pigment depth before selecting treatment. Topical therapy combined with daily SPF 50+ sunscreen is the necessary foundation before any procedural intervention. For cases that have not responded to over-the-counter options, or where previous treatments have caused worsening, professional evaluation is needed to determine the appropriate combination approach for your specific pigment depth and skin type.
If you are experiencing persistent brown or greyish facial patches unresponsive to over-the-counter treatments, or if previous laser or peel procedures have worsened your pigmentation, consult our MOH-accredited dermatologist for accurate depth assessment and a treatment protocol suited to your skin type.
